These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 25713905)

  • 1. Plasma from patients with acute liver failure dampens HepG2 cells to epidermal growth factor induced proliferation response.
    Li W; Long J; Takikawa Y; Suzuki K; Lin S
    Hepatogastroenterology; 2014 Oct; 61(135):2021-7. PubMed ID: 25713905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin efficacy against human hepatocellular carcinoma.
    Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
    Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.
    You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K
    Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of simvastatin on the proliferation of HepG2 cells].
    Liu W; Zhang LF; Zhang YH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):751-3. PubMed ID: 21059291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1.
    Tan Y; Li Y
    Biochem Biophys Res Commun; 2015 Oct; 466(3):592-8. PubMed ID: 26392314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma].
    Xia JT; Li W; Liu YJ; Chen LZ; Wu ZF; Zhang LJ; Wang Q
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):918-21. PubMed ID: 18171527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone increases epirubicin's apoptotic effects in HepG2 cells by S phase cell cycle arrest.
    Chang WT; Lin HL; Chang KL; Ker CG; Huang MC; Chen JS; Kuo KK; Chen YL; Lee KT
    Hepatogastroenterology; 2010; 57(97):107-13. PubMed ID: 20422883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
    Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of cyclin D1 antisense cDNA on human hepatocarcinoma cell line HepG2].
    Xiao ZY; Chen XP; Huang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):768-71. PubMed ID: 16248951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
    Parekh P; Motiwale L; Naik N; Rao KV
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):167-73. PubMed ID: 20133117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor-induced proliferation of chicken primordial germ cells: involvement of calcium/protein kinase C and NFKB1.
    Ge C; Yu M; Petitte JN; Zhang C
    Biol Reprod; 2009 Mar; 80(3):528-36. PubMed ID: 19005168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichlorodiphenyltrichloroethane exposure induces the growth of hepatocellular carcinoma via Wnt/β-catenin pathway.
    Jin XT; Song L; Zhao JY; Li ZY; Zhao MR; Liu WP
    Toxicol Lett; 2014 Feb; 225(1):158-66. PubMed ID: 24355586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms of DHEA and DHEAs on apoptosis and cell cycle arrest via Akt pathway in hepatoma cell lines].
    Jiang YF; Zhao PW; Tan Y; Liu LH; Li MH; Matsuzaki Y; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):441-4. PubMed ID: 17594810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells.
    Saikawa Y; Kubota T; Otani Y; Kitajima M; Modlin IM
    Jpn J Cancer Res; 2001 Oct; 92(10):1102-9. PubMed ID: 11676861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
    Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
    Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.